Clinical trial
A Randomized Controlled Trial to Evaluate the Effect of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Patients With Primary Aldosteronism (The PETAL Trial)
NCT07027254 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial to Evaluate the Effect of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Patients With Primary Aldosteronism (The PETAL Trial)
- Lead sponsor
- Seoul National University Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 25, 2025
- Completion date
- December 1, 2027
- Enrollment
- 90 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
adrenalectomy, aldosterone-producing adenoma, idiopathic hyperaldosteronism, primary aldosteronism, secondary hypertension